![Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf2567/asset/04c611f3-f72d-48ff-9b3b-aee605cc6f06/assets/graphic/abf2567-f2.jpeg)
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances
![Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf2567/asset/1864e7c6-5fee-4841-a56b-a85029d717a4/assets/graphic/abf2567-f4.jpeg)
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances
![Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancer | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf2567/asset/52d6b8c0-98b9-453e-a95f-bd8dd69d505a/assets/graphic/abf2567-f5.jpeg)